Provided by Tiger Trade Technology Pte. Ltd.

ARS PHARMACEUTICALS INC

8.07
-0.4900-5.72%
Post-market: 7.62-0.4500-5.58%19:28 EDT
Volume:2.38M
Turnover:19.21M
Market Cap:797.71M
PE:-4.64
High:8.64
Open:8.57
Low:7.61
Close:8.56
52wk High:18.90
52wk Low:6.66
Shares:98.85M
Float Shares:55.27M
Volume Ratio:1.05
T/O Rate:4.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7400
EPS(LYR):-1.7400
ROE:-92.33%
ROA:-33.04%
PB:6.98
PE(LYR):-4.64

Loading ...

Mar 21, 2024

Major Issues Report

Form 8-K - Current report
Mar 07, 2024

Major Issues Report

Form 8-K - Current report
Feb 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Sep 26, 2023

Major Issues Report

Form 8-K - Current report
Sep 25, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 20, 2023

Major Issues Report

Form 8-K - Current report
Sep 02, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 01, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Sep 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 11, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 28, 2023

Major Issues Report

Form 8-K - Current report
Jun 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Major Issues Report

Form 8-K - Current report